| Metric | შპს მედლაბ 2024 | შპს კრომოს ფარმა საქართველო |
|---|---|---|
| Growth | ||
| Revenue | ₾1.8m | ₾2.1m |
| Revenue growth | — | — |
| Profitability | ||
| EBITDA | ₾582k | ₾59k |
| EBITDA margin | 33.0% | 2.8% |
| Net profit | ₾586k | ₾24k |
| Net margin | 33.2% | 1.1% |
| Balance sheet | ||
| Total assets | ₾1.3m | ₾360k |
| Total equity | ₾586k | ₾317k |
| ROE | 100.0% | 7.5% |